Internal tandem duplication mutations of the FMS-like tyrosine kinase 3 (FLT3) gene (FLT3-ITD) has been discovered in AML with frequencies of 20%, which carry a poor prognosis. This evidence concerns the gene FLT3 and acute myeloid leukemia.